Polaris Market Research recently launched the latest update on Europe Point of Care (PoC) Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use – Market Forecast, 2025-2034 that gives an extensive outlook of the market, analyzing facts, current growth factors, future trends, historical data, attentive opinions, and industry-validated data forecasts.
Europe Point of Care (PoC) Diagnostics Market is currently valued at USD 9.28 billion in 2024 and is anticipated to generate an estimated revenue of USD 13.61 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 3.92% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034
𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
http://www.polarismarketresearch.com/industr…for-sample
The Europe PoC diagnostics market is witnessing strong growth driven by rising healthcare digitalization and demand for rapid testing solutions. Increasing incidence of chronic and infectious diseases boosts adoption across primary care settings.
Governments across Europe are promoting decentralized diagnostic models to reduce hospital burdens and improve patient outcomes. Technological innovations in immunoassays, molecular diagnostics, and biosensor-based platforms enhance test accuracy and usability.
Home-based and pharmacy-based PoC testing is gaining momentum, particularly for diabetes, cardiovascular, and respiratory conditions. Integration with mobile health applications enables real-time data capture and remote monitoring.
Regulatory harmonization under EU standards supports consistent quality and safety guidelines. Growing elderly populations also increase diagnostic needs.
The market benefits from strong investments in healthcare infrastructure.
Overall, demand for rapid, cost-effective solutions continues to shape competitive trends.
Europe Point of Care (PoC) Diagnostics Market Key Growth Drivers
* Expansion of decentralized and near-patient testing facilities
* Rising burden of infectious and chronic diseases across Europe
* Growing demand for rapid and accurate diagnostic solutions
* Increased adoption of molecular PoC platforms
* Supportive regulatory frameworks promoting early diagnosis
* Integration of digital connectivity and data-sharing in PoC devices
* Growing investments in healthcare modernization
Key Player Analysis:
The report provides a detailed analysis of the Europe Point of Care (PoC) Diagnosticss Market key players encompassing their product and service market segmentation, revenue, share, product portfolios, capabilities, market positions, geographic footprints, and entry strategies. The report helps readers comprehend the unique positions that these businesses hold in the developing worldwide market.
Sales figures, gross margin analysis, profit margins, and price patterns concerning each firm have been inculcated in the report.
𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
* bioMérieux
* Boditech Med Inc.
* EKF Diagnostics
* Grifols
* HORIBA Medical / HORIBA ABX SAS
* Nova Biomedical / Nova Biomedical EMEA
* Qiagen
* Roche Diagnostics
* Siemens Healthineers
* Werfen
𝐕𝐢𝐬𝐢𝐭 𝐎𝐮𝐫 𝐖𝐞𝐛𝐬𝐢𝐭𝐞 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
http://www.polarismarketresearch.com/industr…ics-market
Key Findings from The Report:
* The report illustrates an analysis showing product/service consumption in a region along with elements influencing the Europe Point of Care (PoC) Diagnosticss Market in each area.
* Report outlines the global potential and risks that vendors must deal with.
* The analysis identifies the regions and industries with the most potential for growth.
* A competitive market with notable firm rankings, the introduction of new products, corporate growth, and acquisitions is incorporated in the report.
* The research includes business overviews, corporate insights, product benchmarking, and SWOT analysis for each important market participant.
* The report takes into account current developments, motivating factors, obstacles, and geographical constraints that are present in developed regions.
Segmentation Overview:
Europe Point of Care (PoC) Diagnostics Market segmentation analysis is done on the basis of types, applications, regions, and key players. The market’s key demographic, regional, and behavioral data are aimed at helping to determine the characteristics a firm should offer in order to meet the needs of the business.
Also, market maker information is used to categorize the study to better understand clients buying behavior and patterns for the consumer-based market. Our analysts ensure the report is segmented with accurate marketing & sales channels to recognize prospective industry size by revenue and volume.
Europe Point of Care (PoC) Diagnostics Market, Product Outlook (Revenue, USD Billion, 2020-2034)
* Glucose Testing
* Hb1Ac Testing
* Coagulation
* Fertility
* Infectious Diseases
* Cardiac Markers
* Thyroid Stimulating Hormone
* Hematology
* Primary Care Systems
* Decentralized Clinical Chemistry
* Feces
* Lipid Testing
* Cancer Marker
* Blood Gas/Electrolytes
* Ambulatory Chemistry
* Drug Abuse Testing
* Urinalysis
Europe Point of Care (PoC) Diagnostics Market, Mode of Prescription Outlook (Revenue, USD Billion, 2020-2034)
* OTC
* Prescription-based
Europe Point of Care (PoC) Diagnostics Market, End Use Outlook (Revenue, USD Billion, 2020-2034)
* Clinics
* Hospitals
* Home
* Assisted Living Healthcare Facilities
* Laboratory
𝐀𝐬𝐤 𝐀𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐅𝐨𝐫 𝐘𝐨𝐮𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐒𝐚𝐦𝐩𝐥𝐞:
http://www.polarismarketresearch.com/industr…tomization
Key Questions Answered in Report
Q – What is the size of the market for a specific product or service, and what are the primary drivers and challenges?
Ans – Market valued at 9.28 billion in 2024, projected to reach 13.61 billion by 2034 at 3.92% CAGR; primary drivers are self-testing shift, government policies, geriatric population growth, and chronic disease management; challenges include regulatory navigation.
Q – What are the top players in a specific industry or market, as well as their shares, competitive tactics, and strengths and weaknesses?
Ans – Major players include Roche Diagnostics, Siemens Healthineers, bioMérieux, Qiagen, Werfen, Nova Biomedical, EKF Diagnostics; competitive tactics focus on AI integration, antimicrobial resistance testing, and digital health platforms; Germany holds 17.91% share.
Q – What are the present patterns and future growth prospects for a specific sector or market, and what causes are driving these trends?
Ans – Present trends include home-based healthcare, digital connectivity, miniaturization, and novel sensors; future growth driven by remote monitoring, patient-centric care, early disease detection, and preventive care approaches.
Q – What are the opportunities and challenges that businesses in a specific industry face?
Ans – Opportunities include OTC diagnostic expansion, AI-powered devices, data sharing capabilities, and automated systems; challenges include technology adoption, supply chain management, and climate change navigation.
Q – What are the most recent industry developments that can be used to produce new revenue streams?
Ans – May 2025 Neoul launched miLab BCM AI-powered PoC device integrating blood morphology analysis and CBC delivering rapid diagnostics and March 2025 EU4Health aimed for sub-one-hour antimicrobial testing development creating revenue streams.
News From
Polaris Market Research &…
Category: Industry Reports & Market Analysis Profile: Polaris Market Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight and market intelligence to our customers across various industries. We at Polaris are obliged to serve our client base across the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, ch …
This email address is being protected from spambots. You need JavaScript enabled to view it.
